chr2-239960704-C-T

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_004544.4(NDUFA10):​c.*414G>A variant causes a 3 prime UTR change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.325 in 1,159,702 control chromosomes in the GnomAD database, including 63,641 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.28 ( 6954 hom., cov: 34)
Exomes 𝑓: 0.33 ( 56687 hom. )

Consequence

NDUFA10
NM_004544.4 3_prime_UTR

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:4

Conservation

PhyloP100: -2.03

Publications

18 publications found
Variant links:
Genes affected
NDUFA10 (HGNC:7684): (NADH:ubiquinone oxidoreductase subunit A10) The protein encoded by this gene is a component of 42 kDa complex I, the first enzyme complex in the electron transport chain of mitochondria. This protein has NADH dehydrogenase activity and oxidoreductase activity. It transfers electrons from NADH to the respiratory chain. A mutation in this gene was found in an individual with Leigh syndrome. [provided by RefSeq, Apr 2016]
NDUFA10 Gene-Disease associations (from GenCC):
  • mitochondrial complex I deficiency, nuclear type 22
    Inheritance: AR Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae), G2P
  • mitochondrial disease
    Inheritance: AR Classification: MODERATE Submitted by: ClinGen
  • Leigh syndrome with leukodystrophy
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
  • Leigh syndrome
    Inheritance: AR Classification: LIMITED Submitted by: ClinGen

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.94).
BP6
Variant 2-239960704-C-T is Benign according to our data. Variant chr2-239960704-C-T is described in ClinVar as Benign. ClinVar VariationId is 335193.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.364 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
NDUFA10NM_004544.4 linkc.*414G>A 3_prime_UTR_variant Exon 10 of 10 ENST00000252711.7 NP_004535.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
NDUFA10ENST00000252711.7 linkc.*414G>A 3_prime_UTR_variant Exon 10 of 10 1 NM_004544.4 ENSP00000252711.2

Frequencies

GnomAD3 genomes
AF:
0.285
AC:
43269
AN:
152074
Hom.:
6952
Cov.:
34
show subpopulations
Gnomad AFR
AF:
0.138
Gnomad AMI
AF:
0.374
Gnomad AMR
AF:
0.305
Gnomad ASJ
AF:
0.272
Gnomad EAS
AF:
0.377
Gnomad SAS
AF:
0.191
Gnomad FIN
AF:
0.454
Gnomad MID
AF:
0.232
Gnomad NFE
AF:
0.342
Gnomad OTH
AF:
0.276
GnomAD4 exome
AF:
0.331
AC:
333556
AN:
1007510
Hom.:
56687
Cov.:
33
AF XY:
0.328
AC XY:
156879
AN XY:
478388
show subpopulations
African (AFR)
AF:
0.122
AC:
2560
AN:
21018
American (AMR)
AF:
0.303
AC:
3172
AN:
10476
Ashkenazi Jewish (ASJ)
AF:
0.283
AC:
2651
AN:
9358
East Asian (EAS)
AF:
0.377
AC:
4500
AN:
11948
South Asian (SAS)
AF:
0.185
AC:
9154
AN:
49598
European-Finnish (FIN)
AF:
0.438
AC:
3461
AN:
7904
Middle Eastern (MID)
AF:
0.213
AC:
479
AN:
2254
European-Non Finnish (NFE)
AF:
0.345
AC:
296089
AN:
858952
Other (OTH)
AF:
0.319
AC:
11490
AN:
36002
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.481
Heterozygous variant carriers
0
11729
23459
35188
46918
58647
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
11678
23356
35034
46712
58390
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.284
AC:
43274
AN:
152192
Hom.:
6954
Cov.:
34
AF XY:
0.288
AC XY:
21425
AN XY:
74404
show subpopulations
African (AFR)
AF:
0.138
AC:
5713
AN:
41542
American (AMR)
AF:
0.306
AC:
4677
AN:
15288
Ashkenazi Jewish (ASJ)
AF:
0.272
AC:
945
AN:
3470
East Asian (EAS)
AF:
0.378
AC:
1956
AN:
5178
South Asian (SAS)
AF:
0.190
AC:
915
AN:
4822
European-Finnish (FIN)
AF:
0.454
AC:
4800
AN:
10578
Middle Eastern (MID)
AF:
0.240
AC:
70
AN:
292
European-Non Finnish (NFE)
AF:
0.342
AC:
23282
AN:
67996
Other (OTH)
AF:
0.272
AC:
576
AN:
2116
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.500
Heterozygous variant carriers
0
1551
3102
4652
6203
7754
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
446
892
1338
1784
2230
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.313
Hom.:
20372
Bravo
AF:
0.269
Asia WGS
AF:
0.259
AC:
900
AN:
3478

ClinVar

Significance: Benign
Submissions summary: Benign:4
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:2
May 13, 2021
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Leigh syndrome Benign:1
Jan 13, 2018
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -

Mitochondrial complex I deficiency, nuclear type 1 Benign:1
Jan 13, 2018
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.94
CADD
Benign
0.52
DANN
Benign
0.60
PhyloP100
-2.0
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs13424612; hg19: chr2-240900121; API